Works matching IS 17588340 AND DT 2011 AND VI 3 AND IP 3
Results: 3
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 3, p. 127, doi. 10.1177/1758834011401951
- By:
- Publication type:
- Article
Maintenance therapy in advanced non-small cell lung cancer: evolution, tolerability and outcomes.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 3, p. 139, doi. 10.1177/1758834011399306
- By:
- Publication type:
- Article
Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 3, p. 113, doi. 10.1177/1758834010397569
- By:
- Publication type:
- Article